88 - Endemic Fungi: The Latest on Diagnosis, Treatment and Risk Assessment

Thursday, October 20, 2022

3:15 PM – 4:30 PM US ET

Location: 207 AB

Watch the live stream on the conference website.

All relevant financial disclosures have been mitigated.

Moderator(s)

Marina Nunez, MD, PHD

Professor Department of Internal Medicine, Section on Infectious Diseases
Wake Forest School of Medicine, NC, United States

Disclosure(s): No financial relationships to disclose
Andrej Spec, MD, MSCI

Assistant Professor
Washington University in St. Louis
St. Louis, Missouri, United States

Disclosure(s): Astellas: Grant/Research Support ()

Slides

Faculty(s)

Janis Blair, MD

Infectious diseases consultant
Division of Infectious diseases
Mayo Clinic Hospital
Phoenix, AZ, United States

Disclosure(s): No financial relationships to disclose

Slides
Andrej Spec, MD, MSCI

Assistant Professor
Washington University in St. Louis
St. Louis, Missouri, United States

Disclosure(s): Astellas: Grant/Research Support ()

Slides
Ella Ariza Heredia, MD

Associate Professor
The University of Texas MD Anderson Cancer Center
Houston, TX, United States

Disclosure(s): Merck & Co. Inc: Grant/Research Support (Ongoing)

Slides

Disclosure(s):

Marina Nunez, MD, PHD: No financial relationships to disclose

Andrej Spec, MD, MSCI: Astellas: Grant/Research Support ()

Janis E. Blair, MD: No financial relationships to disclose

Ella J. Ariza Heredia, MD: Merck & Co. Inc: Grant/Research Support (Ongoing)

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1.25 hours of MOC Credit
CNE Credits: Maximum of 1.25 hours of ANCC Credit
ACPE Credits: ACPE 1.25 contact hours of pharmacy CE
ACPE Number: JA0007082-0000-22-002-L01-P

Learning Objectives:

At the conclusion of this session, participants will be able to:

provide an overview, with a focus on the most recent data, on the diagnosis and treatment of histoplasmosis, blastomycosis and coccidioidomycosis;
describe the vulnerability of the various groups of immunocompromised hosts to develop histoplasmosis, blastomycosis and coccidioidomycosis, and to outline risk assessment practices

Presentations:

3:15 PM – 3:40 PM US ET

Diagnosis of Histoplasmosis/Blastomycosis/Coccidioidomycosis - An Update
Speaker: Janis E. Blair, MD – Mayo Clinic Hospital
3:40 PM – 4:05 PM US ET

Treatment of Histoplasmosis/Blastomycosis/Coccidioidomycosis - An Update
Speaker: Andrej Spec, MD, MSCI – Washington University in St. Louis
4:05 PM – 4:30 PM US ET

Histoplasmosis, Blastomycosis, Coccidioidomycosis and the Immunocompromised Host - Risk Assessment
Speaker: Ella J. Ariza Heredia, MD – The University of Texas MD Anderson Cancer Center